Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

The epidemiology of amyloidosis in Australia.

Wisniowski B, McLeod D, Adams R, Harvey Y, Armes J, Papadimos D, Brown I, McGuire L, Mollee P.

Amyloid. 2019;26(sup1):132-133. doi: 10.1080/13506129.2019.1582481. No abstract available.

PMID:
31343339
2.

Primary squamous carcinoma of breast - a rare entity: report of two cases and review of the literature.

Vythianathan M, Fox P, Rhodes G, Armes JE.

Pathology. 2019 Aug;51(5):529-531. doi: 10.1016/j.pathol.2019.03.003. Epub 2019 Jun 13. No abstract available.

PMID:
31202482
3.

The epidemiology of amyloidosis in Queensland, Australia.

Wisniowski B, McLeod DSA, Adams R, Harvey Y, Brown I, McGuire L, Armes J, Mollee P.

Br J Haematol. 2019 Sep;186(6):829-836. doi: 10.1111/bjh.16000. Epub 2019 May 31.

PMID:
31148162
4.

Prescribing fitness apps for people with cancer: a preliminary assessment of content and quality of commercially available apps.

Martín Payo R, Harris J, Armes J.

J Cancer Surviv. 2019 Jun;13(3):397-405. doi: 10.1007/s11764-019-00760-2. Epub 2019 Apr 28.

PMID:
31030308
5.

Specialist breast cancer nurses' views on implementing a fear of cancer recurrence intervention in practice: a mixed methods study.

Cruickshank S, Steel E, Fenlon D, Armes J, Banks E, Humphris G.

Support Care Cancer. 2019 Apr 17. doi: 10.1007/s00520-019-04762-9. [Epub ahead of print]

PMID:
30997595
6.

Systematic evaluation of Patient-Reported Outcome protocol content and reporting in cancer trials.

Kyte D, Retzer A, Ahmed K, Keeley T, Armes J, Brown JM, Calman L, Gavin A, Glaser AW, Greenfield DM, Lanceley A, Taylor RM, Velikova G, Brundage M, Efficace F, Mercieca-Bebber R, King MT, Turner G, Calvert M.

J Natl Cancer Inst. 2019 Apr 11. pii: djz038. doi: 10.1093/jnci/djz038. [Epub ahead of print]

7.

Adaptation and Implementation of a Mobile Phone-Based Remote Symptom Monitoring System for People With Cancer in Europe.

Furlong E, Darley A, Fox P, Buick A, Kotronoulas G, Miller M, Flowerday A, Miaskowski C, Patiraki E, Katsaragakis S, Ream E, Armes J, Gaiger A, Berg G, McCrone P, Donnan P, McCann L, Maguire R.

JMIR Cancer. 2019 Mar 14;5(1):e10813. doi: 10.2196/10813.

8.

Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer.

Tanay MA, Armes J.

Eur J Cancer Care (Engl). 2019 May;28(3):e13011. doi: 10.1111/ecc.13011. Epub 2019 Feb 20.

PMID:
30790382
9.

Network Analysis of the Multidimensional Symptom Experience of Oncology.

Papachristou N, Barnaghi P, Cooper B, Kober KM, Maguire R, Paul SM, Hammer M, Wright F, Armes J, Furlong EP, McCann L, Conley YP, Patiraki E, Katsaragakis S, Levine JD, Miaskowski C.

Sci Rep. 2019 Feb 19;9(1):2258. doi: 10.1038/s41598-018-36973-1.

10.

Speech, language and swallowing impairments in functional neurological disorder: a scoping review.

Barnett C, Armes J, Smith C.

Int J Lang Commun Disord. 2019 May;54(3):309-320. doi: 10.1111/1460-6984.12448. Epub 2018 Dec 27. Review.

PMID:
30592118
11.

Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-b.

Snell CE, Gough M, Liu C, Middleton K, Pyke C, Shannon C, Woodward N, Hickey TE, Armes JE, Tilley WD.

Br J Cancer. 2018 Nov;119(11):1316-1325. doi: 10.1038/s41416-018-0331-3. Epub 2018 Nov 9.

PMID:
30410061
12.

The conceptual models and mechanisms of action that underpin advance care planning for cancer patients: A systematic review of randomised controlled trials.

Lin CP, Evans CJ, Koffman J, Armes J, Murtagh FEM, Harding R.

Palliat Med. 2019 Jan;33(1):5-23. doi: 10.1177/0269216318809582. Epub 2018 Oct 26.

13.

Missed opportunities for physical activity management at key points throughout the chemotherapy pathway for colorectal survivors: an observational interview study.

Veal I, Peat N, Jones GD, Tsianakas V, Armes J.

Support Care Cancer. 2019 Apr;27(4):1215-1222. doi: 10.1007/s00520-018-4472-y. Epub 2018 Oct 11.

PMID:
30310988
14.

ACTIVE - a randomised feasibility trial study protocol of a behavioural intervention to reduce fatigue in women undergoing radiotherapy for early breast cancer: study protocol.

Courtier N, Gaze S, Armes J, Smith A, Radley L, Armytage J, Simmonds M, Johnson A, Gambling T, Hopkinson J.

Pilot Feasibility Stud. 2018 Jun 11;4:85. doi: 10.1186/s40814-018-0275-7. eCollection 2018.

15.

L1 Retrotransposon Heterogeneity in Ovarian Tumor Cell Evolution.

Nguyen THM, Carreira PE, Sanchez-Luque FJ, Schauer SN, Fagg AC, Richardson SR, Davies CM, Jesuadian JS, Kempen MHC, Troskie RL, James C, Beaven EA, Wallis TP, Coward JIG, Chetty NP, Crandon AJ, Venter DJ, Armes JE, Perrin LC, Hooper JD, Ewing AD, Upton KR, Faulkner GJ.

Cell Rep. 2018 Jun 26;23(13):3730-3740. doi: 10.1016/j.celrep.2018.05.090.

16.

The emerging role of digital health in monitoring and supporting people living with cancer and the consequences of its treatments.

Harris J, Cheevers K, Armes J.

Curr Opin Support Palliat Care. 2018 Sep;12(3):268-275. doi: 10.1097/SPC.0000000000000362. Review.

PMID:
29927756
17.

Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study.

Crawley D, Garmo H, Rudman S, Stattin P, Zethelius B, Armes J, Holmberg L, Adolfsson J, Van Hemelrijck M.

BMJ Open. 2018 Mar 16;8(3):e020787. doi: 10.1136/bmjopen-2017-020787.

18.

Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol.

Retzer A, Keeley T, Ahmed K, Armes J, Brown JM, Calman L, Copland C, Efficace F, Gavin A, Glaser A, Greenfield DM, Lanceley A, Taylor RM, Velikova G, Brundage M, Mercieca-Bebber R, King MT, Calvert M, Kyte D.

BMJ Open. 2018 Feb 3;8(2):e017282. doi: 10.1136/bmjopen-2017-017282.

19.

Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs.

Kalter J, Verdonck-de Leeuw IM, Sweegers MG, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Aitken JF, Armes J, Arving C, Boersma LJ, Braamse AMJ, Brandberg Y, Chambers SK, Dekker J, Ell K, Ferguson RJ, Gielissen MFM, Glimelius B, Goedendorp MM, Graves KD, Heiney SP, Horne R, Hunter MS, Johansson B, Kimman ML, Knoop H, Meneses K, Northouse LL, Oldenburg HS, Prins JB, Savard J, van Beurden M, van den Berg SW, Brug J, Buffart LM.

Psychooncology. 2018 Apr;27(4):1150-1161. doi: 10.1002/pon.4648. Epub 2018 Mar 15. Review.

20.

ER and PR expression and survival after endometrial cancer.

Smith D, Stewart CJR, Clarke EM, Lose F, Davies C, Armes J, Obermair A, Brennan D, Webb PM, Nagle CM, Spurdle AB.

Gynecol Oncol. 2018 Feb;148(2):258-266. doi: 10.1016/j.ygyno.2017.11.027. Epub 2017 Dec 6.

PMID:
29217139
21.

Histologic Evaluation of Explanted Tissue-Engineered Bovine Pericardium (CardioCel).

Prabhu S, Armes JE, Bell D, Justo R, Venugopal P, Karl T, Alphonso N.

Semin Thorac Cardiovasc Surg. 2017 Autumn;29(3):356-363. doi: 10.1053/j.semtcvs.2017.05.017. Epub 2017 Jun 1.

PMID:
29195576
22.

Congruence Between Latent Class and K-Modes Analyses in the Identification of Oncology Patients With Distinct Symptom Experiences.

Papachristou N, Barnaghi P, Cooper BA, Hu X, Maguire R, Apostolidis K, Armes J, Conley YP, Hammer M, Katsaragakis S, Kober KM, Levine JD, McCann L, Patiraki E, Paul SM, Ream E, Wright F, Miaskowski C.

J Pain Symptom Manage. 2018 Feb;55(2):318-333.e4. doi: 10.1016/j.jpainsymman.2017.08.020. Epub 2017 Aug 30.

23.

Ectopic Intralaryngo-Tracheal Thyroid Tissue Causing Neonatal Death.

Furnas L, Safa H, Hutchinson F, Joseph L, Armes JE.

Fetal Pediatr Pathol. 2017 Oct;36(5):412-415. doi: 10.1080/15513815.2017.1336659. Epub 2017 Jul 27.

PMID:
28749718
24.

A feasibility study of the Mini-AFTER telephone intervention for the management of fear of recurrence in breast cancer survivors: a mixed-methods study protocol.

Cruickshank S, Steel E, Fenlon D, Armes J, Scanlon K, Banks E, Humphris G.

Pilot Feasibility Stud. 2017 Jul 20;4:22. doi: 10.1186/s40814-017-0161-8. eCollection 2018. Erratum in: Pilot Feasibility Stud. 2017 Oct 24;3:48.

25.

Application of Whole Genome Sequencing Technology in the Investigation of Genetic Causes of Fetal, Perinatal, and Early Infant Death.

Armes JE, Williams M, Price G, Wallis T, Gallagher R, Matsika A, Joy C, Galea M, Gardener G, Leach R, Swagemakers SM, Tearle R, Stubbs A, Harraway J, van der Spek PJ, Venter DJ.

Pediatr Dev Pathol. 2018 Jan-Feb;21(1):54-67. doi: 10.1177/1093526617715528. Epub 2017 Jun 22.

PMID:
28641477
26.

The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer.

Maguire R, Fox PA, McCann L, Miaskowski C, Kotronoulas G, Miller M, Furlong E, Ream E, Armes J, Patiraki E, Gaiger A, Berg GV, Flowerday A, Donnan P, McCrone P, Apostolidis K, Harris J, Katsaragakis S, Buick AR, Kearney N.

BMJ Open. 2017 Jun 6;7(5):e015016. doi: 10.1136/bmjopen-2016-015016.

27.

Isolated Ventricular Noncompaction Cardiomyopathy Presenting as Fetal Hydrops at 24 Weeks Gestation.

Armes JE, Squires L, Lourie R, Williams M, Gallagher R, Price G, Stubbs A, Swagemakers SM, van der Spek PJ, Harraway J, Thomas J, Venter DJ.

Pediatr Dev Pathol. 2017 Jun;20(3):245-250. doi: 10.1177/1093526616686235. Epub 2017 Jan 25.

PMID:
28521630
28.

Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis.

Pettit S, Cresta E, Winkley K, Purssell E, Armes J.

PLoS One. 2017 May 3;12(5):e0176941. doi: 10.1371/journal.pone.0176941. eCollection 2017. Review.

29.

Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.

Snell CE, Gough M, Middleton K, Hsieh M, Furnas L, Seidl B, Gibbons K, Pyke C, Shannon C, Woodward N, Armes JE.

J Clin Pathol. 2017 Nov;70(11):954-960. doi: 10.1136/jclinpath-2016-204304. Epub 2017 Apr 17.

PMID:
28416639
30.

Anxiety after completion of treatment for early-stage breast cancer: a systematic review to identify candidate predictors and evaluate multivariable model development.

Harris J, Cornelius V, Ream E, Cheevers K, Armes J.

Support Care Cancer. 2017 Jul;25(7):2321-2333. doi: 10.1007/s00520-017-3688-6. Epub 2017 Apr 12. Review.

31.

The outcome of papillary lesions of the breast diagnosed by standard core needle biopsy within a BreastScreen Australia service.

Armes JE, Galbraith C, Gray J, Taylor K.

Pathology. 2017 Apr;49(3):267-270. doi: 10.1016/j.pathol.2016.12.346. Epub 2017 Feb 24.

PMID:
28238415
32.

CanWalk: a feasibility study with embedded randomised controlled trial pilot of a walking intervention for people with recurrent or metastatic cancer.

Tsianakas V, Harris J, Ream E, Van Hemelrijck M, Purushotham A, Mucci L, Green JS, Fewster J, Armes J.

BMJ Open. 2017 Feb 15;7(2):e013719. doi: 10.1136/bmjopen-2016-013719.

33.

The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin's and non-Hodgkin's lymphomas: A scoping review.

Fox P, Darley A, Furlong E, Miaskowski C, Patiraki E, Armes J, Ream E, Papadopoulou C, McCann L, Kearney N, Maguire R.

Eur J Oncol Nurs. 2017 Feb;26:63-82. doi: 10.1016/j.ejon.2016.12.008. Epub 2016 Dec 22. Review.

PMID:
28069154
34.

Prevalence of cancer chemotherapy-related problems, their relation to health-related quality of life and associated supportive care: a cross-sectional survey.

Wagland R, Richardson A, Ewings S, Armes J, Lennan E, Hankins M, Griffiths P.

Support Care Cancer. 2016 Dec;24(12):4901-4911. Epub 2016 Jul 27.

PMID:
27465050
35.

Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol.

Ahmed K, Kyte D, Keeley T, Efficace F, Armes J, Brown JM, Calman L, Copland C, Gavin A, Glaser A, Greenfield DM, Lanceley A, Taylor R, Velikova G, Brundage M, Mercieca-Bebber R, King MT, Calvert M.

BMJ Open. 2016 Sep 21;6(9):e012863. doi: 10.1136/bmjopen-2016-012863.

36.

Extracorporeal Life Support in Multisystem Smooth Muscle Dysfunction Syndrome.

Prabhu S, Fox S, Mattke A, Armes JE, Alphonso N.

World J Pediatr Congenit Heart Surg. 2017 Nov;8(6):750-753. doi: 10.1177/2150135116658457. Epub 2016 Aug 22.

PMID:
27549731
37.

Survivorship care and support following treatment for breast cancer: a multi-ethnic comparative qualitative study of women's experiences.

Tompkins C, Scanlon K, Scott E, Ream E, Harding S, Armes J.

BMC Health Serv Res. 2016 Aug 18;16(1):401. doi: 10.1186/s12913-016-1625-x.

38.

Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy.

Obermair A, Brennan DJ, Baxter E, Armes JE, Gebski V, Janda M.

Gynecol Oncol Res Pract. 2016 Feb 9;3:1. doi: 10.1186/s40661-016-0023-8. eCollection 2016.

39.

Interstitial lung disease in infancy: A general approach.

Hines EJ, Walsh M, Armes JE, Douglas T, Chawla J.

J Paediatr Child Health. 2016 Apr;52(4):370-6. doi: 10.1111/jpc.13162. Review.

PMID:
27145498
40.

Ovarian Microcystic Stromal Tumor: A Rare Clinical Manifestation of Familial Adenomatous Polyposis.

Liu C, Gallagher RL, Price GR, Bolton E, Joy C, Harraway J, Venter DJ, Armes JE.

Int J Gynecol Pathol. 2016 Nov;35(6):561-565.

PMID:
27015438
41.

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.

Harrington BS, He Y, Davies CM, Wallace SJ, Adams MN, Beaven EA, Roche DK, Kennedy C, Chetty NP, Crandon AJ, Flatley C, Oliveira NB, Shannon CM, deFazio A, Tinker AV, Gilks CB, Gabrielli B, Brennan DJ, Coward JI, Armes JE, Perrin LC, Hooper JD.

Br J Cancer. 2016 Feb 16;114(4):417-26. doi: 10.1038/bjc.2015.471. Epub 2016 Feb 4.

42.

The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis.

Tanay MAL, Armes J, Ream E.

Eur J Cancer Care (Engl). 2017 Sep;26(5). doi: 10.1111/ecc.12443. Epub 2016 Jan 20. Review.

PMID:
26786536
43.

The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy.

Miaskowski C, Cooper BA, Aouizerat B, Melisko M, Chen LM, Dunn L, Hu X, Kober KM, Mastick J, Levine JD, Hammer M, Wright F, Harris J, Armes J, Furlong E, Fox P, Ream E, Maguire R, Kearney N.

Eur J Cancer Care (Engl). 2017 May;26(3). doi: 10.1111/ecc.12437. Epub 2016 Jan 18.

PMID:
26777053
44.

A web-based intervention (RESTORE) to support self-management of cancer-related fatigue following primary cancer treatment: a multi-centre proof of concept randomised controlled trial.

Foster C, Grimmett C, May CM, Ewings S, Myall M, Hulme C, Smith PW, Powers C, Calman L, Armes J, Breckons M, Corner J, Fenlon D, Batehup L, Lennan E, R May C, Morris C, Neylon A, Ream E, Turner L, Yardley L, Richardson A.

Support Care Cancer. 2016 Jun;24(6):2445-53. doi: 10.1007/s00520-015-3044-7. Epub 2015 Dec 7.

45.

Tracheal Atresia with Segmental Esophageal Duplication: An Unusual Anatomic Arrangement.

Gaerty K, Thomas JT, Petersen S, Tan E, Kumar S, Gardener G, Armes J.

Pediatr Dev Pathol. 2016 Mar-Apr;19(2):154-8. doi: 10.2350/15-08-1685-CR.1. Epub 2015 Sep 14.

PMID:
26367770
46.

Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.

He Y, Wu AC, Harrington BS, Davies CM, Wallace SJ, Adams MN, Palmer JS, Roche DK, Hollier BG, Westbrook TF, Hamidi H, Konecny GE, Winterhoff B, Chetty NP, Crandon AJ, Oliveira NB, Shannon CM, Tinker AV, Gilks CB, Coward JI, Lumley JW, Perrin LC, Armes JE, Hooper JD.

Oncogene. 2016 Jan 28;35(4):468-78. doi: 10.1038/onc.2015.101. Epub 2015 Apr 20.

47.

CanWalk: study protocol for a randomized feasibility trial of a walking intervention for people with recurrent or metastatic cancer.

Harris J, Tsianakas V, Ream E, Van Hemelrijck M, Purushotham A, Mucci L, Green JS, Robb K, Fewster J, Armes J.

Pilot Feasibility Stud. 2015 Mar 12;1:7. eCollection 2015.

48.

Managing fatigue after cancer treatment: development of RESTORE, a web-based resource to support self-management.

Foster C, Calman L, Grimmett C, Breckons M, Cotterell P, Yardley L, Joseph J, Hughes S, Jones R, Leonidou C, Armes J, Batehup L, Corner J, Fenlon D, Lennan E, Morris C, Neylon A, Ream E, Turner L, Richardson A.

Psychooncology. 2015 Aug;24(8):940-9. doi: 10.1002/pon.3747. Epub 2015 Feb 2.

PMID:
25648410
49.

Diffuse lung disease of infancy: a pattern-based, algorithmic approach to histological diagnosis.

Armes JE, Mifsud W, Ashworth M.

J Clin Pathol. 2015 Feb;68(2):100-10. doi: 10.1136/jclinpath-2014-202685. Epub 2014 Dec 4. Review.

50.

Treatment-related problems experienced by cancer patients undergoing chemotherapy: a scoping review.

Wagland R, Richardson A, Armes J, Hankins M, Lennan E, Griffiths P.

Eur J Cancer Care (Engl). 2015 Sep;24(5):605-17. doi: 10.1111/ecc.12246. Epub 2014 Oct 8. Review.

PMID:
25296389

Supplemental Content

Support Center